We are live on ! Find out more
Pendal Group

Pendal Group Portfolio holdings

AUM $11.6B Turnover 28.7%
1-Year Est. Return 12.87%
This Fund
S&P 500
This Quarter Est. Return
+1.65%
1 Year Est. Return
-12.87%
3 Year Est. Return
+52.75%
5 Year Est. Return
+103.82%
10 Year Est. Return
–
AUM
$12.1B
AUM Growth
+$1.2B
Cap. Flow
+$1.49B
Cap. Flow %
12.26%
Top 10 Hldgs %
30.95%
Holding
675
New
129
Increased
199
Reduced
220
Closed
109
Avg Time Held
1.6 years
Top 10 Avg Time Held
1.4 years
Top 20 Avg Time Held
1.4 years

Top Buys

Rank Stock Value
1
BNTX icon
BioNTech
BNTX
+$463M
2
BABA icon
Alibaba
BABA
+$168M
3
UNH icon
UnitedHealth
UNH
+$142M
4
LIN icon
Linde
LIN
+$136M
5
CHKP icon
Check Point Software Technologies
CHKP
+$129M

Top Sells

Rank Stock Value
1
PRAH
PRA Health Sciences
PRAH
+$115M
2
MEDP icon
Medpace
MEDP
+$115M
3
ORCL icon
Oracle
ORCL
+$112M
4
MKSI icon
MKS
MKSI
+$99.1M
5
ARMK icon
Aramark
ARMK
+$92.8M

Sector Composition

Rank Sector Weight
1 Technology 20.62%
2 Healthcare 16.66%
3 Financials 15.34%
4 Consumer Discretionary 9.67%
5 Communication Services 7.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
INFO icon
1
DELISTED
IHS Markit
INFO
$514M 4.24%
4,406,176
-118,765
-3% -$14M
2017 Q2
17 quarters
APTV icon
2
Aptiv
APTV
$7.63B
$504M 4.16%
3,383,722
+314,213
+10% +$48.9M
2020 Q2
5 quarters
ACN icon
3
Accenture
ACN
$129B
$491M 4.05%
1,534,825
-149,008
-9% -$48.5M
2017 Q2
17 quarters
ICLR icon
4
Icon
ICLR
$14.3B
$443M 3.66%
1,692,148
+32,095
+2% +$7.8M
2017 Q3
16 quarters
MGA icon
5
Magna International
MGA
$16B
$401M 3.31%
5,332,730
+542,901
+11% +$44.7M
2021 Q1
2 quarters
BNTX icon
6
BioNTech
BNTX
$20.2B
$397M 3.28%
+1,455,825
New +$463M
2021 Q3
0 quarters
PM icon
7
Philip Morris
PM
$291B
$293M 2.41%
3,086,207
-119,056
-4% -$12M
2017 Q2
17 quarters
LIN icon
8
Linde
LIN
$235B
$243M 2.01%
829,619
+447,052
+117% +$136M
2020 Q1
6 quarters
TMO icon
9
Thermo Fisher Scientific
TMO
$256B
$235M 1.94%
411,422
+185,074
+82% +$102M
2018 Q3
12 quarters
LBTYK icon
10
Liberty Global Class C
LBTYK
$3.3B
$229M 1.89%
7,780,465
+3,945,011
+103% +$110M
2018 Q3
12 quarters
ATO icon
11
Atmos Energy
ATO
$28.8B
$222M 1.83%
2,514,877
-48,352
-2% -$4.68M
2020 Q1
6 quarters
SRE icon
12
Sempra
SRE
$50.1B
$220M 1.82%
3,483,592
+125,026
+4% +$8.25M
2017 Q2
17 quarters
ICE icon
13
Intercontinental Exchange
ICE
$96.1B
$217M 1.79%
1,890,544
+386,234
+26% +$45.8M
2017 Q2
17 quarters
PGR icon
14
Progressive
PGR
$133B
$216M 1.78%
2,384,757
+18,167
+0.8% +$1.73M
2020 Q2
5 quarters
HSIC icon
15
Henry Schein
HSIC
$9.29B
$209M 1.72%
2,739,522
+1,159,051
+73% +$89.2M
2021 Q1
2 quarters
EXC icon
16
Exelon
EXC
$47.2B
$205M 1.7%
5,957,793
-1,503,438
-20% -$51.4M
2017 Q2
17 quarters
LHX icon
17
L3Harris
LHX
$48B
$189M 1.56%
858,744
-155,301
-15% -$35.3M
2017 Q2
17 quarters
MTB icon
18
M&T Bank
MTB
$30.3B
$186M 1.54%
1,247,067
+320,485
+35% +$44.4M
2019 Q4
7 quarters
ORCL icon
19
Oracle
ORCL
$349B
$185M 1.53%
2,121,143
-1,273,079
-38% -$112M
2017 Q2
17 quarters
MSFT icon
20
Microsoft
MSFT
$3.72T
$164M 1.35%
582,390
-163,952
-22% -$47.7M
2017 Q2
17 quarters
IBN icon
21
ICICI Bank
IBN
$126B
$142M 1.17%
8,191,997
+1,999,043
+32% +$37.5M
2017 Q2
17 quarters
UNH icon
22
UnitedHealth
UNH
$299B
$134M 1.11%
343,950
+343,233
+47,871% +$142M
2017 Q2
17 quarters
TEAM icon
23
Atlassian
TEAM
$33.7B
$131M 1.08%
335,188
-133,828
-29% -$44.7M
2019 Q2
9 quarters
A icon
24
Agilent Technologies
A
$49.6B
$130M 1.07%
826,389
-154,559
-16% -$25M
2017 Q3
16 quarters
V icon
25
Visa
V
$752B
$127M 1.05%
571,905
+521,397
+1,032% +$122M
2017 Q2
17 quarters

Similar funds

Pendal Group's Q3 2021 Portfolio in Review

As of Q3 2021, Pendal Group held 675 positions worth $12.1B, up 11% from $10.9B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Pendal Group deployed $1.49B of net new capital in Q3 2021, opening 129 new positions and adding to 199 existing holdings. Its largest new stake was BioNTech: 1,455,825 shares worth $397M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Medpace, an estimated $115M trimmed.

  • Pendal Group's largest Q3 2021 buy was BioNTech: 1,455,825 shares worth $397M.
  • Pendal Group added most to Alibaba in Q3 2021, an estimated $168M increase.
  • Pendal Group's biggest Q3 2021 reduction was Medpace, cutting an estimated $115M.
  • Pendal Group fully exited PRA Health Sciences in Q3 2021, selling an estimated $115M.
  • Pendal Group's ten largest holdings make up 31% of its $12.1B portfolio in Q3 2021.
  • Pendal Group opened 129 new positions and closed 109 in Q3 2021.
  • Pendal Group's portfolio value rose 11% quarter-over-quarter to $12.1B.

Based on Pendal Group's 13F filing for Q3 2021, filed 5 Nov 2021.